Literature DB >> 22514410

Varicella zoster immune globulin use in neonates and infants.

.   

Abstract

Entities:  

Year:  1996        PMID： 22514410      PMCID： PMC3327373          DOI： 10.1155/1996/910592

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN： 1180-2332


× No keyword cloud information.
  10 in total

1.  Failure of varicella-zoster immunoglobulin in modification of severe congenital varicella.

Authors:  S S Bakshi; T C Miller; M Kaplan; M R Hammerschlag; A Prince; A A Gershon
Journal:  Pediatr Infect Dis       Date:  1986 Nov-Dec

2.  Fatal varicella-zoster infection in a newborn treated with varicella-zoster immunoglobulin.

Authors:  S M King; M Gorensek; E L Ford-Jones; S E Read
Journal:  Pediatr Infect Dis       Date:  1986 Sep-Oct

3.  Disseminated varicella in a neonate: implications for immunoprophylaxis of neonates postnatally exposed to varicella.

Authors:  L Rubin; R Leggiadro; M T Elie; P Lipsitz
Journal:  Pediatr Infect Dis       Date:  1986 Jan-Feb

4.  Fatal neonatal varicella infection.

Authors:  P Holland; D Isaacs; E R Moxon
Journal:  Lancet       Date:  1986-11-15       Impact factor: 79.321

5.  Management of varicella exposures in the neonatal intensive care unit.

Authors:  W L Gold; J E Boulton; C Goldman; A Gershon; S P Steinberg; R Chua; D E Low; A McGeer
Journal:  Pediatr Infect Dis J       Date:  1993-11       Impact factor: 2.129

6.  Outbreak of varicella in a newborn intensive care nursery.

Authors:  T L Gustafson; Z Shehab; P A Brunell
Journal:  Am J Dis Child       Date:  1984-06

7.  Varicella zoster immunoglobulin after postnatal exposure to varicella: survey of experts.

Authors:  C L Wurzel; L G Rubin; L R Krilov
Journal:  Pediatr Infect Dis J       Date:  1987-05       Impact factor: 2.129

8.  Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus.

Authors:  E Miller; J E Cradock-Watson; M K Ridehalgh
Journal:  Lancet       Date:  1989-08-12       Impact factor: 79.321

9.  Deaths from varicella in infants.

Authors:  S R Preblud; D J Bregman; L L Vernon
Journal:  Pediatr Infect Dis       Date:  1985 Sep-Oct

10.  Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella.

Authors:  J A Zaia; M J Levin; S R Preblud; J Leszczynski; G G Wright; R J Ellis; A C Curtis; M A Valerio; J LeGore
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226
  10 in total
  2 in total

1.  Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: Varicella outcomes and safety results from a large, open-label, expanded-access program.

Authors:  Myron J Levin; Jennifer M Duchon; Geeta K Swamy; Anne A Gershon
Journal:  PLoS One       Date:  2019-07-03       Impact factor: 3.240

2.  Safety and Varicella Outcomes in In Utero-Exposed Newborns and Preterm Infants Treated With Varicella Zoster Immune Globulin (VARIZIG): A Subgroup Analysis of an Expanded-Access Program.

Authors:  Jennifer M Duchon; Myron J Levin; Anne A Gershon
Journal:  J Pediatric Infect Dis Soc       Date:  2020-09-17       Impact factor: 3.164
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.